C-reactive protein and C1q regulate platelet adhesion and activation on adsorbed immunoglobulin G and albumin

Immunology and Cell Biology

Volumn 86, Issue 5, 2008, Pages 466-474

  Skoglund, Caroline ^a   Wetterö, Jonas ^a   Skogh, Thomas ^a   Sjöwall, Christopher ^a   Tengvall, Pentti ^a   Bengtsson, Torbjorn ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Acute phase response; C reactive protein (CRP); Complement; Inflammation; Plasma protein adsorption; Platelets

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT FACTOR 1Q; COMPLEMENT FACTOR I; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; PHOSPHATIDYLSERINE; THROMBOXANE B2;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; METHYLATION; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

BLOOD PLATELETS; C-REACTIVE PROTEIN; CELL SHAPE; COMPLEMENT C1Q; HUMANS; IMMUNOGLOBULIN G; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; PLATELET ADHESIVENESS; SERUM ALBUMIN; THROMBOXANE B2;

EID: 46749083444     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.9     Document Type: Article

References (57)

1. Tillet WS, Francis TJ. Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561-571.
2. Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 2006; 106: 291-297.
3. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999; 42: 23-30.
4. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 2005; 117: 104-111.
5. Wilson AM, Swan JD, Ding H, Zhang Y, Whitbourn RJ, Gurry J et al. Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy. Atherosclerosis 2006; 191: 175-181.
6. Danenberg HD, Kantak N, Grad E, Swaminathan RV, Lotan C, Edelman ER. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol 2007; 78: 246-252.
7. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783-1790.
8. Bhakdi S, Torzewski M, Paprotka K, Schmitt S, Barsoom H, Suriyaphol P et al. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation 2004; 109: 1870-1876.
9. Rodriguez W, Mold C, Kataranovski M, Hutt JA, Marnell LL, Verbeek JS et al. C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fc gamma receptors. J Immunol 2007; 178: 530-538.
10. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108: 1930-1932.
11. Kuta AE, Baum LL. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med 1986; 164: 321-326.
12. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol 1996; 156: 4815-4820.
13. Bang R, Marnell L, Mold C, Stein MP, Clos KT, Chivington-Buck C et al. Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis. J Biol Chem 2005; 280: 25095-25102.
14. Oksjoki R, Kovanen PT, Meri S, Pentikainen MO. Function and regulation of the complement system in cardiovascular diseases. Front Biosci 2007; 12: 4696-4708.
15. Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. The role of complement in biomaterial-induced inflammation. Mol Immunol 2007; 44: 82-94.
16. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004; 25: 5681-5703.
17. Berman S, Gewurz H, Mold C. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. J Immunol 1986; 136: 1354-1359.
18. McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J Immunol 2006; 176: 2950-2957.
19. Potempa LA, Zeller JM, Fiedel BA, Kinoshita CM, Gewurz H. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 1988; 12: 391-405.
20. Wang HW, Sui SF. Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins. Biochem Biophys Res Commun 2001; 288: 75-79.
21. Ji SR, Wu Y, Zhu L, Potempa LA, Sheng FL, Lu W et al. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J 2007; 21: 284-294.
22. Sjöwall C, Eriksson P, Almer S, Skogh T. Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J Autoimmun 2002; 19: 155-160.
23. Khreiss T, Jozsef L, Potempa LA, Filep JG. Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 2004; 110: 2713-2720.
24. Von Hundelshausen PWC. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40.
25. Peerschke EI, Ghebrehiwet B. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis. Immunobiology 1998; 199: 239-249.
26. Peerschke EI, Murphy TK, Ghebrehiwet B. Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost 2003; 89: 331-339.
27. Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol 1995; 103: 466-471.
28. Wetterö J, Askendal A, Bengtsson T, Tengvall P. On the binding of complement to solid artificial surfaces in vitro. Biomaterials 2002; 23: 981-991.
29. Andersson J, Ekdahl KN, Lambris JD, Nilsson B. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005; 26: 1477-1485.
30. Tengvall P, Askendal A, Lundström I. Complement activation by IgG immobilized on methylated silicon. J Biomed Mater Res 1996; 31: 305-312.
31. Wetterö J, Tengvall P, Bengtsson T. Platelets stimulated by IgG-coated surfaces bind and activate neutrophils through a selectin-dependent pathway. Biomaterials 2003; 24: 1559-1573.
32. Nimeri G, hman L, Elwing H, Wetterö J, Bengtsson T. The influence of plasma proteins and platelets on oxygen radical production and F-actin distribution in neutrophils adhering to polymer surfaces. Biomaterials 2002; 23: 1785-1795.
33. Liu L, Elwing H, Karlsson A, Nimeri G, Dahlgren C. Surface-related triggering of the neutrophil respiratory burst. Characterization of the response induced by IgG adsorbed to hydrophilic and hydrophobic glass surfaces. Clin Exp Immunol 1997; 109: 204-210.
34. Briede JJ, Heemskerk JW, Hemker HC, Lindhout T. Heterogeneity in microparticle formation and exposure of anionic phospholipids at the plasma membrane of single adherent platelets. Biochim Biophys Acta 1999; 1451: 163-172.
35. Sjöwall C, Wetterö J, Bengtsson T, Askendal A, Almroth G, Skogh T et al. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction. Biochem Biophys Res Commun 2007; 352: 251-258.
36. Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C et al. C-reactive protein binding to Fc gamma RIIa on human monocytes and neutrophils is allele-specific. J Clin Invest 2000; 105: 369-376.
37. Manolov DE, Rocker C, Hombach V, Nienhaus GU, Torzewski J. Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with Fc gamma RIIa. Arterioscler Thromb Vasc Biol 2004; 24: 2372-2377.
38. Chi M, Tridandapani S, Zhong W, Coggeshall KM, Mortensen RF. C-reactive protein induces signaling through Fc gamma RIIa on HL-60 granulocytes. J Immunol 2002; 168: 1413-1418.
39. Canobbio I, Stefanini L, Guidetti GF, Balduini C, Torti M. A new role for Fc gamma RIIA in the potentiation of human platelet activation induced by weak stimulation. Cell Signal 2006; 18: 861-870.
40. Fiedel BA, Gewurz H. Cleaved forms of C-reactive protein are associated with platelet inhibition. J Immunol 1986; 136: 2551-2555.
41. Yaron G, Brill A, Dashevsky O, Yosef-Levi IM, Grad E, Danenberg HD et al. C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis. Br J Haematol 2006; 134: 426-431.
42. Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J Thromb Haemost 2006; 4: 2035-2042.
43. Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005; 201: 871-879.
44. Peerschke EI, Ghebrehiwet B. C1q augments platelet activation in response to aggregated Ig. J Immunol 1997; 159: 5594-5598.
45. Peerschke EI, Reid KB, Ghebrehiwet B. Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med 1993; 178: 579-587.
46. Vollertsen RS, McDuffie FC, Bowie EJ. Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG. Clin Exp Immunol 1983; 52: 423-429.
47. Sloand JA, Mehta RL, Schmer G, Rosenfeld SI. Influence of C1q on the interaction of model immune complexes with human platelets. Clin Immunol Immunopathol 1995; 76: 127-134.
48. Jancar S, Sanchez Crespo M. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol 2005; 26: 48-55.
49. Hed J, Johansson M, Skogh T. The role of negative charge in the complement-dependent dissociation of IgG-mediated aggregation. Scand J Immunol 1985; 21: 43-47.
50. Peerschke EI, Ghebrehiwet B. Platelet C1q receptor interactions with collagen- and C1q-coated surfaces. J Immunol 1990; 145: 2984-2988.
51. Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE. Topology and structure of the C1q-binding site on C-reactive protein. J Immunol 2001; 166: 3998-4004.
52. Kaneko N, Masuyama J, Nara H, Hirata D, Iwamoto M, Okazaki H et al. Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis. J Rheumatol 2002; 29: 2106-2113.
53. Bengtsson T, Grenegård M. Platelets amplify chemotactic peptide-induced changes in F-actin and calcium in human neutrophils. Eur J Cell Biol 1994; 63: 345-349.
54. Frank RD, Dresbach H, Thelen H, Sieberth HG. Glutardialdehyde induced fluorescence technique (GIFT): a new method for the imaging of platelet adhesion on biomaterials. J Biomed Mater Res 2000; 52: 374-381.
55. Allen RD, Zacharski LR, Widirstky ST, Rosenstein R, Zaitlin LM, Burgess DR. Transformation and motility of human platelets: details of the shape change and release reaction observed by optical and electron microscopy. J Cell Biol 1979; 83: 126-142.
56. Vroman L, Adams AL. Identification of rapid changes at plasma-solid interfaces. J Biomed Mater Res 1969; 3: 43-67.
57. Elwing H. Protein absorption and ellipsometry in biomaterial research. Biomaterials 1998; 19: 397-406.